Literature DB >> 19393263

Neuroinflammation and astrocytic reaction in the course of Phoneutria nigriventer (armed-spider) blood-brain barrier (BBB) opening.

Maria Alice da Cruz-Höfling1, Catarina Rapôso, Liana Verinaud, Gabriela Mariotoni Zago.   

Abstract

Phoneutria nigriventer spider venom (PNV) causes uneven BBB permeability throughout different cerebral regions. Little is known about cellular and molecular responses which course with the PNV-induced BBB opening. We investigate by immunohistochemistry (IHC) and Western blotting (WB), the GFAP, S100, IFN-gamma and TNF-alpha proteins expression in hippocampus and cerebellum after different time-points from venom or saline intravenous injection. All proteins variably altered its expression temporally and regionally. WB showed increased GFAP content at 15-45 min followed by a shift below the control level which was less pronounced in hippocampus. IHC showed reactive gliosis during all the trial period. In cerebellum, GFAP was mostly immunodetected in astrocytes of the molecular layer (Bergmann glia), as was S100 protein. The maximum S100 immunolabeling was achieved at 5h. IFN-gamma and TNF-alpha, expressed mostly by hippocampal neurons, increased along the trial period, suggesting a role in BBB permeability. In envenomed animals, closer contacts astrocyte-astrocyte, granule cells-granule cells and astrocytes-Purkinje cells were observed in cerebellum. Closer contacts between neurons-neurons-astrocytes-astrocytes were also seen in hippocampus. PNV contains serotonin, histamine, Ca(2+) channels-blocking toxins, some of which affect glutamate release. The hypothesis that such substances plus the cytokines generated, could have a role in BBB permeability, and that calcium homeostasis loss and disturbance of glutamate release are associated with the marked GFAP/S100 reaction in Bergmann glia is discussed. The existence of a CNS mechanism of defense modulated differentially for fast synthesis and turnover of GFAP, S100, IFN-gamma and TNF-alpha proteins was evident. A clear explanation for this differential modulation is unclear, but likely result from regional differences in astrocytic/neuronal populations, BBB tightness, and/or extent/distribution of microvasculature and/or ion channels density/distribution. Such differences would respond for transient characteristics of BBB disruption. This in vivo model is useful for studies on drug delivery throughout the CNS and experimental manipulation of the BBB.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19393263     DOI: 10.1016/j.neuro.2009.04.004

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  9 in total

1.  Effect of Phoneutria nigriventer venom on the expression of junctional protein and P-gp efflux pump function in the blood-brain barrier.

Authors:  Catarina Rapôso; Paulo Alexandre Miranda Odorissi; Alexandre L R Oliveira; Hiroshi Aoyama; Carmen Verissima Ferreira; Liana Verinaud; Karina Fontana; Roberta R Ruela-de-Sousa; Maria Alice da Cruz-Höfling
Journal:  Neurochem Res       Date:  2012-06-09       Impact factor: 3.996

2.  Are Synchronized Changes in Connexin-43 and Caveolin-3 a Bystander Effect in a Phoneutria nigriventer Venom Model of Blood-Brain Barrier Breakdown?

Authors:  Edilene Siqueira Soares; Monique Culturato Padilha Mendonça; Thalita Rocha; Evanguedes Kalapothakis; Maria Alice da Cruz-Höfling
Journal:  J Mol Neurosci       Date:  2016-04-11       Impact factor: 3.444

3.  Expression of VEGF and Flk-1 and Flt-1 receptors during blood-brain barrier (BBB) impairment following Phoneutria nigriventer spider venom exposure.

Authors:  Monique C P Mendonça; Edilene S Soares; Leila M Stávale; Catarina Rapôso; Andressa Coope; Evanguedes Kalapothakis; Maria Alice da Cruz-Höfling
Journal:  Toxins (Basel)       Date:  2013-12-18       Impact factor: 4.546

4.  Age-Related Modulations of AQP4 and Caveolin-1 in the Hippocampus Predispose the Toxic Effect of Phoneutria nigriventer Spider Venom.

Authors:  Edilene S Soares; Leila M Stávale; Monique C P Mendonça; Andressa Coope; Maria Alice da Cruz-Höfling
Journal:  Int J Mol Sci       Date:  2016-11-23       Impact factor: 5.923

5.  Vascular endothelial growth factor increases during blood-brain barrier-enhanced permeability caused by Phoneutria nigriventer spider venom.

Authors:  Monique C P Mendonça; Edilene S Soares; Leila M Stávale; Evanguedes Kalapothakis; Maria Alice Cruz-Höfling
Journal:  Biomed Res Int       Date:  2014-08-27       Impact factor: 3.411

6.  Triggering of protection mechanism against Phoneutria nigriventer spider venom in the brain.

Authors:  Catarina Rapôso; Paulo Alexandre Miranda Odorissi; Stefania Fioravanti Savioli; Rafaela Chitarra Rodrigues Hell; Gustavo Ferreira Simões; Roberta R Ruela-de-Sousa; Alexandre Leite Rodrigues de Oliveira; Maria Alice da Cruz-Höfling
Journal:  PLoS One       Date:  2014-09-11       Impact factor: 3.240

7.  YAP Is a Critical Inducer of SOCS3, Preventing Reactive Astrogliosis.

Authors:  Zhihui Huang; Ying Wang; Guoqing Hu; Jiliang Zhou; Lin Mei; Wen-Cheng Xiong
Journal:  Cereb Cortex       Date:  2015-12-17       Impact factor: 5.357

8.  Sustained hyperammonemia induces TNF-a IN Purkinje neurons by activating the TNFR1-NF-κB pathway.

Authors:  Tiziano Balzano; Yaiza M Arenas; Sherry Dadsetan; Jerónimo Forteza; Sara Gil-Perotin; Laura Cubas-Nuñez; Bonaventura Casanova; Francisco Gracià; Natalia Varela-Andrés; Carmina Montoliu; Marta Llansola; Vicente Felipo
Journal:  J Neuroinflammation       Date:  2020-02-22       Impact factor: 8.322

9.  Astrocytic YAP protects the optic nerve and retina in an experimental autoimmune encephalomyelitis model through TGF-β signaling.

Authors:  Qian Wu; Xuemeng Miao; Jingjing Zhang; Ludan Xiang; Xiuchun Li; Xiaomei Bao; Siyu Du; Mianxian Wang; Shuangda Miao; Yiren Fan; Wei Wang; Xingxing Xu; Xiya Shen; Danlu Yang; Xiwu Wang; Yuanyuan Fang; Lixin Hu; Xuyi Pan; Haoru Dong; Hui Wang; Ying Wang; Jia Li; Zhihui Huang
Journal:  Theranostics       Date:  2021-07-25       Impact factor: 11.556

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.